Nalu Bio. is Drug Discovery in United States that focus on wellness ingredients business. Founded in 2019. They cover business area such as developer, cannabinoid, cognitive wellness ingredient, treatment, pain, addiction, mental health issue, readily available material, reliable manufacturing technology, high capital investment cost, hemp extraction, biosynthesis, client, high quality, consistently pure and safe ingredient, therapeutic.
2019
( 7 years old in 2026 )
Wellness Ingredients
-
38 Keyes Avenue
Suite 200
San Francisco, CA 94129
United States
Private
developercannabinoidcognitive wellness ingredienttreatmentpainaddictionmental health issuereadily available materialreliable manufacturing technologyhigh capital investment costhemp extractionbiosynthesisclienthigh qualityconsistently pure and safe ingredienttherapeutic
* We use standard office opening hours in near Nalu Bio.'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Nalu Bio. is Drug Discovery business from United States that founded in 2019 (7 years old in 2026), Nalu Bio. business is focusing on Wellness Ingredients.
Nalu Bio. headquarter office and corporate office address is located in 38 Keyes Avenue Suite 200 San Francisco, CA 94129 United States.
Nalu Bio. was founded in United States.
In 2026, Nalu Bio. is currently focus on wellness ingredients sector.
Above is snippet of Google Trends for "wellness ingredients" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Nalu Bio., any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
